SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Speaker
Greg Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
St. Louis, MO

Title
: Strategies for Diagnosis and Treatment of Adult ADHD in Primary Care
Activity/Course #:
: NCME309
Cost:
: Free
Release/Start Date:
: Oct 26 2016
Expiration Date:
: Oct 25 2017
Topics:
: Psychiatry
Target Audience:
: Primary Care Providers
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.25 pharmacology hour(s)
Hardware/Software Requirements:
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care 2016 conference. The topic of this webcast is Strategies for Diagnosis and Treatment of Adult ADHD in Primary Care and features Greg Mattingly, MD.
Learning Objective(s):
After completing this program participants should be able to:
  1. Describe ADHD symptom profiles and common presentations in a primary care setting
  2. Identify risks for coexisting disorders in adult patients with ADHD with emphasis on anxiety disorders, mood disorders, and substance use/abuse disorder
  3. Implement appropriate pharmacologic treatment for adults diagnosed with ADHD designed to improve compliance, minimize side effects and maximize outcomes in a busy primary care setting
  4. Use adult ADHD assessment and treatment tools for assessment, treatment and follow-up monitoring


This webcast was recorded live and is being used with the permission of the presenter.

How To Obtain Your CME Certificate

  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 80% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education (which includes 0.25 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Greg Mattingly, MD, Speaker, has the following relationship to disclose: Speaker - Allergan, Lundbeck, Merck, Otsuka, Shire, Sunovion, Takeda and Vanda; Consultant - Alkermes, Allergan, Forum, Lundbeck, Merck, Otsuka, Perdue, Rhodes, Shire, Sunovion, Takeda and Vanda; Research - Akili, Alcobra, Alkermes, Allergan, Boehringer, Forum, Janssen, Medgenics, NLS-1 Pharma AG, Reckitt Benckiser, Shire, Sunovion, Supernus and Takeda.

Gustavo Alva, MD, DFAPA, Planning Committee, has the following relationship to disclose: Research Support - Intra-Cellular, Trans-Tech, Novartis, Neurion; Clinical Research - Suven, Neurotrope, Janssen, Allergan, Lundbeck.

Birgit Amann, MD, Planning Committee, has the following relationship to disclose: Speaker - Arbor, Takeda and Lundbeck, Otsuka; Speaker/Consultant - Rhodes, Shire, Tris, Neos.

Richard H. Anderson, MD, PhD, Planning Committee, has the following relationship to disclose: Speaker - Lundbeck and Takeda; Researcher - Akili, Alcobra, Alkermes, Allergan, Boehringer, Forum, Janssen, Medgenics, NLS-1 Pharma AG, Reckitt Benckiser, Shire, Sunovion, Supernus and Takeda.

C. Brendan Montano, MD, Planning Committee, has the following relationship to disclose: Speaker Bureau - Shire, Takeda; Advisor - Neos.

Gregg Sherman, MD
, Course Director, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Sheila Lucas, CWEP, Activity Planning Committee, has no relationships to disclose.

Cheryl C. Kay, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by is supported by an independent medical educational grant from Shire.